News / Health

Could Existing Drugs Be Used to Treat Deadly MERS Virus?

Can Existing Drugs Help Fight Deadly MERS Virus?i
X
Steve Baragona
May 07, 2014 12:49 PM
A deadly new illness has appeared in the Middle East, and doctors have no medicine to stop it. So far, Middle East Respiratory Syndrome does not spread easily from person to person. But it has killed roughly a quarter of those infected, and experts are watching it closely in case it becomes more contagious. In the scramble to find a cure, scientists are turning up some unexpected candidates. VOA’s Steve Baragona has more.
A lethal new virus that originated in the Middle East is spreading and there is no drug to fight it.

Or is there? Scientists are scouring the medicine cabinet for existing drugs to fight Middle East Respiratory Syndrome (MERS) and they're finding some unexpected candidates. 

In lab studies, drugs against cancer, neurological disorders and other ailments show promise to help treat MERS. 

Why would a cancer drug stop a virus? Scientists don’t necessarily know. But the fact that they work at all is helping researchers understand previously unknown ways in which the drugs -- and the viruses -- function.

'Extraordinary' virus

MERS has killed about a quarter of the roughly 500 people infected since it was first detected in 2012. 

“The mortality rate is extraordinary,” said National Institute of Allergy and Infectious Diseases Director Anthony Fauci. “That’s unheard of with common respiratory infections. That’s the very, very sobering news about this. The somewhat encouraging news so far is that it is not readily spread from person to person.”
Passengers walk past the medical quarantine area showing information sheets on Middle East respiratory syndrome (MERS) at the arrivals section of Manila's International Airport in Paranaque, south of Manila, April 16, 2014.Passengers walk past the medical quarantine area showing information sheets on Middle East respiratory syndrome (MERS) at the arrivals section of Manila's International Airport in Paranaque, south of Manila, April 16, 2014.
The virus that causes MERS is related to the SARS virus that erupted out of China in 2003. SARS killed about 10 percent of its approximately 8,000 victims but it was much more contagious than MERS is. Experts are keeping a close eye on MERS in case it mutates to become more infectious. 

Long wait for new drugs

Doctors have little to offer MERS patients. There are no drugs approved by the U.S. Food and Drug Administration. 

And developing a new drug is time-consuming and expensive. Virologist Matt Frieman at the University of Maryland at Baltimore says candidates that work well in a test tube often do not work in living cells. 

“And the ones that do, when you now take them from a cell to an animal model of the disease, most of them don’t work,” he said. 

Drugs that are effective in animal tests still need to go through three stages of clinical trials to be sure they help sick people without doing more harm than good.

“Starting from scratch, to go from basic research in an academic lab to getting a product licensed by the FDA, can take a decade and tons and tons of money,” said immunologist Erik Stemmy, who oversees MERS research grants for the National Institute of Allergy and Infectious Diseases (NIAID).

Robot testing

That’s why NIAID is backing efforts to look for drugs that are already FDA-approved for something else that might also work against MERS.

Robots are lending a hand. Automated systems developed in just the last few years can screen hundreds of drugs at a time.

“You can do a lot of quick, test-tube, petri-dish screens to see if, hey, does this have any efficacy or not,” Stemmy said. “That’s what’s really moving this field forward.”

Stemmy added that researchers are using the same techniques to hunt for existing drugs that fight antibiotic-resistant germs, another growing public health problem with little or nothing new in the drug-development pipeline.

The robots have turned up about two dozen drugs that Frieman is putting through further tests. 

“Most of them have not been used against viruses at all,” he said.
 


It is not always clear how these drugs work, even for their intended purpose. Frieman says only recently did scientists begin designing medicines against specific parts of a cell’s machinery. Many started out as plant extracts or other compounds that treated a disease, even though doctors did not know why or how. 

“A lot of these drugs do things that either were not known before,” he said, “or they target the things that everyone thought they targeted, but no one knew that that was involved in virus replication.”

When a virus infects a cell, it hijacks the cell’s machinery to replicate, or make copies of itself. In pictures from one experiment, Frieman points out how one type of cellular protein important in infection is normally scattered around the cell, but moves to the center of the cell when treated with one drug.

“We don’t know why they do this with the drug. But we know that the drug that does this inhibits replication of the virus.”

'Promising candidates'

These drugs still need to be tested to see if they work as well in animals as they do in a petri dish. Only then would they be considered for sick patients.

But the fact that they are already FDA-approved is one less hurdle they need to clear.

“I think that we have some definite promising therapeutic candidates in the pipeline,” Stemmy said. “And I think that if things progress with the infections and the spread, I think we’re in a really good position to be able to respond.”

And what they are learning from MERS may put scientists in a good position to respond to other new viruses.

You May Like

Anti-Terror Drills Highlight China’s Push Into Central Asia

China, Russia, several central Asian countries wrap up massive anti terrorism military drills in Inner Mongolia More

Erdogan’s First Step: Secure More Power in New Role in Turkey

Erdogan was sworn in as Turkey's first popularly elected president on Thursday; he picked former foreign minister Ahmet Davutoglu as PM More

Pakistan Army Fails to Break Political Deadlock

PM Sharif claims he didn't ask army to defuse crisis; military rejects claim More

This forum has been closed.
Comment Sorting
Comments
     
by: rand moore from: SZ, China
May 07, 2014 6:43 PM
Since MERS is said to be related to SARS, maybe researchers should review what Hong Kong (and other SARs researchers) did to fight that disease, including what medicines they tried. There's a chance that what was effective in treating SARs patients could be effective against MERS.

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Battles Pro-Russia Rebel Assaulti
X
Daniel Schearf
August 29, 2014 9:30 PM
After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Ukraine Battles Pro-Russia Rebel Assault

After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Growing Business Offers Paint with a Twist of Wine

Two New Orleans area women started a small business seven years ago with one thing in mind: to help their neighbors relieve the stress of coping with a hurricane's aftermath. Today their business, which pairs painting and a little bit of wine, has become one of the fastest growing franchises across the U.S. VOA’s June Soh met the entrepreneurs at their newest franchise location in the Washington suburbs.
Video

Video Ebola Vaccine Trials To Begin Next Week

The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.
Video

Video Asian Bacteria Threatens Florida Orange Trees

Florida's citrus fruit industry is facing a serious threat from a bacteria carried by the Asian insect called psyllid. The widespread infestation again highlights the danger of transferring non-native species to American soil. VOA’s George Putic reports.
Video

Video Aging Will Reduce Economic Growth Worldwide in Coming Decades

The world is getting older, fast. And as more people retire each year, fewer working-age people will be there to replace them. Bond rating agency Moody’s says that will lead to a decline in household savings; reducing global investments - which in turn, will lead to slower economic growth around the world. But experts say it’s not too late to mitigate the economic impact of the world’s aging populations. Mil Arcega has more.
Video

Video Is West Doing Enough to Tackle Islamic State?

U.S. President Barack Obama has ruled out sending ground troops to Iraq to fight militants of the so-called Islamic State, or ISIS, despite officials in Washington describing the extremist group as the biggest threat the United States has faced in years. Henry Ridgwell reports from London on the growing uncertainty over whether the West’s response to ISIS will be enough to defeat the terrorist threat.
Video

Video Coalition to Fight Islamic State Could Reward Assad

The United States along with European and Mideast allies are considering a broader assault against Islamic State fighters who have spread from Syria into Iraq and risk further destabilizing an already troubled region. But as VOA State Department Correspondent Scott Stearns reports, confronting those militants could end up helping the embattled Syrian President Bashar al-Assad.
Video

Video Made in America Socks Get Toehold in Online Fashion Market

Three young entrepreneurs are hoping to revolutionize the high-end sock industry by introducing all-American creations of their own. And they’re doing most of it the old-fashioned way. VOA’s Julie Taboh recently caught up with them to learn what goes into making their one-of-a-kind socks.
Video

Video Americans, Ex-Pats Send Relief Supplies to West Africa

Health organizations from around the world are sending supplies and specialists to the West African countries that are dealing with the worst Ebola outbreak in history. On a smaller scale, ordinary Americans and African expatriates living in the United States are doing the same. VOA's Carol Pearson reports.
Video

Video America's Most Popular Artworks Displayed in Public Places

Public places in cities across America were turned into open-air art galleries in August. Pictures of the nation’s most popular artworks were displayed on billboards, bus shelters, subway platforms and more. The idea behind “Art Everywhere,” a collaborative campaign by five major museums is to allow more people to enjoy art and learn about the country’s culture and history. Faiza Elmasry has more.
Video

Video Chinese Doctors Use 3-D Spinal Implant

A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video India’s Leprosy Battle Stymied by Continuing Stigma

Medical advancements in the treatment of leprosy have greatly diminished its impact around the world, largely eliminating the disease from most countries. India made great strides in combating leprosy, but still accounts for a majority of the world’s new cases each year, and the number of newly infected Indians is rising - more than 130,000 recorded last year. Doctors there say the problem has more to do with society than science. Shaikh Azizur Rahman reports from Kolkata.

AppleAndroid